Allworth Financial LP Acquires 4,313 Shares of iShares Biotechnology ETF $IBB

Allworth Financial LP boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 246.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,062 shares of the financial services provider’s stock after buying an additional 4,313 shares during the period. Allworth Financial LP’s holdings in iShares Biotechnology ETF were worth $767,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Ramirez Asset Management Inc. acquired a new stake in shares of iShares Biotechnology ETF in the first quarter valued at approximately $26,000. Berkshire Money Management Inc. purchased a new stake in iShares Biotechnology ETF in the second quarter valued at approximately $28,000. Harbor Asset Planning Inc. acquired a new stake in iShares Biotechnology ETF during the 2nd quarter worth $31,000. Trust Co. of Toledo NA OH acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at about $32,000. Finally, Security National Bank purchased a new position in iShares Biotechnology ETF during the 2nd quarter worth $38,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $164.19 on Friday. The stock’s fifty day moving average is $151.00 and its two-hundred day moving average is $136.95. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $166.29.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.